Hector Bonilla

5.7k total citations · 2 hit papers
63 papers, 2.2k citations indexed

About

Hector Bonilla is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, Hector Bonilla has authored 63 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Infectious Diseases, 21 papers in Neurology and 15 papers in Epidemiology. Recurrent topics in Hector Bonilla's work include Long-Term Effects of COVID-19 (21 papers), Antimicrobial Resistance in Staphylococcus (12 papers) and COVID-19 Clinical Research Studies (10 papers). Hector Bonilla is often cited by papers focused on Long-Term Effects of COVID-19 (21 papers), Antimicrobial Resistance in Staphylococcus (12 papers) and COVID-19 Clinical Research Studies (10 papers). Hector Bonilla collaborates with scholars based in United States, Australia and Qatar. Hector Bonilla's co-authors include Tracey G. Simon, Yan Peng, Raymond T. Chung, Adeel A. Butt, Upinder Singh, Prasanna Jagannathan, Karen B. Jacobson, Carol A. Kauffman, Suzanne Bradley and Jason R. Andrews and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Hector Bonilla

52 papers receiving 2.1k citations

Hit Papers

Gastrointestinal symptoms and fecal shedding of SARS-CoV-... 2022 2026 2023 2024 2022 2023 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hector Bonilla United States 23 1.1k 638 448 293 238 63 2.2k
Cristina Mussini Italy 29 1.4k 1.3× 900 1.4× 203 0.5× 360 1.2× 892 3.7× 159 3.1k
Christoph Wenisch Austria 29 1.0k 0.9× 1.0k 1.6× 178 0.4× 383 1.3× 61 0.3× 143 3.4k
Laura Milazzo Italy 23 679 0.6× 752 1.2× 102 0.2× 244 0.8× 155 0.7× 75 2.0k
James P. Luby United States 29 1.1k 1.1× 1.8k 2.8× 250 0.6× 190 0.6× 95 0.4× 90 3.1k
Bruno Cacopardo Italy 31 779 0.7× 1.2k 1.9× 92 0.2× 225 0.8× 253 1.1× 171 3.1k
Symeon Metallidis Greece 19 752 0.7× 379 0.6× 230 0.5× 207 0.7× 64 0.3× 101 1.6k
Emanuele Focà Italy 23 1.1k 1.0× 376 0.6× 336 0.8× 149 0.5× 375 1.6× 106 2.0k
Stefan Schmiedel Germany 23 551 0.5× 294 0.5× 333 0.7× 280 1.0× 280 1.2× 101 1.8k
Svend Ellermann‐Eriksen Denmark 27 565 0.5× 700 1.1× 182 0.4× 286 1.0× 63 0.3× 99 2.0k
Wolfgang Graninger Austria 30 802 0.7× 826 1.3× 79 0.2× 405 1.4× 29 0.1× 105 2.8k

Countries citing papers authored by Hector Bonilla

Since Specialization
Citations

This map shows the geographic impact of Hector Bonilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hector Bonilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hector Bonilla more than expected).

Fields of papers citing papers by Hector Bonilla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hector Bonilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hector Bonilla. The network helps show where Hector Bonilla may publish in the future.

Co-authorship network of co-authors of Hector Bonilla

This figure shows the co-authorship network connecting the top 25 collaborators of Hector Bonilla. A scholar is included among the top collaborators of Hector Bonilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hector Bonilla. Hector Bonilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shankar, Vishnu, Julie Wilhelmy, Vamsee Mallajosyula, et al.. (2025). Oxidative stress is a shared characteristic of ME/CFS and Long COVID. Proceedings of the National Academy of Sciences. 122(28). e2426564122–e2426564122. 3 indexed citations
2.
Jagannathan, Prasanna, Haley Hedlin, Blake Shaw, et al.. (2025). Longitudinal Patient-Reported Outcome Trajectories in Long COVID: Findings From the STOP-PASC Clinical Trial. Open Forum Infectious Diseases. 12(10). ofaf634–ofaf634.
3.
Swank, Zoe, Phillip Grant, Hector Bonilla, et al.. (2025). Single-Cell and Plasma Proteomics Do Not Differentiate Patients With and Without SARS-CoV-2 Antigenemia in Convalescence in a Cohort of 100 Patients. Open Forum Infectious Diseases. 12(9). ofaf515–ofaf515.
4.
Grant, Philip, Hector Bonilla, Marisa Holubar, et al.. (2024). Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution. Science Translational Medicine. 16(773). eadr1032–eadr1032. 15 indexed citations
5.
Miglis, Mitchell G., Lü Tian, Hector Bonilla, et al.. (2024). Post-COVID-19 Vaccination and Long COVID: Insights from Patient-Reported Data. Vaccines. 12(12). 1427–1427. 1 indexed citations
6.
Bonilla, Hector, et al.. (2023). New Alcohol Sensitivity in Patients With Post-acute Sequelae of SARS-CoV-2 (PASC): A Case Series. Cureus. 15(12). e51286–e51286. 1 indexed citations
7.
Geng, Linda N., Hector Bonilla, Robert W. Shafer, Mitchell G. Miglis, & Phillip C. Yang. (2023). The Use of Nirmatrelvir-ritonavir in a Case of Breakthrough Long COVID. 0(0). 394–396. 6 indexed citations
8.
Bonilla, Hector, Lü Tian, Vincent C. Marconi, et al.. (2023). Low-dose naltrexone use for the management of post-acute sequelae of COVID-19. International Immunopharmacology. 124(Pt B). 110966–110966. 12 indexed citations
9.
Murugesan, Kanagavel, Prasanna Jagannathan, Jonathan Altamirano, et al.. (2022). Long-Term Accuracy of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Interferon-γ Release Assay and Its Application in Household Investigation. Clinical Infectious Diseases. 75(1). e314–e321. 7 indexed citations
10.
Natarajan, Aravind, Soumaya Zlitni, Erin F. Brooks, et al.. (2022). Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. 3(6). 371–387.e9. 234 indexed citations breakdown →
11.
Jacobson, Karen B., Hector Bonilla, Aruna Subramanian, et al.. (2021). Patients With Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: A Cautionary Tale During a Global Pandemic. Clinical Infectious Diseases. 73(3). e826–e829. 129 indexed citations
12.
Verma, Renu, Giovanny J. Martínez-Colón, Prasanna Jagannathan, et al.. (2021). SARS-CoV-2 Subgenomic RNA Kinetics in Longitudinal Clinical Samples. Open Forum Infectious Diseases. 8(7). ofab310–ofab310. 17 indexed citations
13.
Jacobson, Karen B., Natasha Purington, Julie Parsonnet, et al.. (2021). Inflammatory but not respiratory symptoms are associated with ongoing upper airway viral shedding in outpatients with uncomplicated COVID-19. Diagnostic Microbiology and Infectious Disease. 102(3). 115612–115612.
14.
Shields, Ryan K., et al.. (2017). Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria. PLoS ONE. 12(3). e0173286–e0173286. 50 indexed citations
15.
Eckard, Allison Ross, Traci Leong, Ann Avery, et al.. (2013). Short Communication: High Prevalence of Vitamin D Deficiency in HIV-Infected and HIV-Uninfected Pregnant Women. AIDS Research and Human Retroviruses. 29(9). 1224–1228. 9 indexed citations
16.
Bonilla, Hector, et al.. (2012). Epidemiology and clinical outcomes of patients withFusobacteriumbacteraemia. Epidemiology and Infection. 141(2). 325–329. 25 indexed citations
17.
Spellberg, Brad, David R. Andes, Anne M. Anglim, et al.. (2009). Safety and Outcomes of Open-Label Deferasirox Iron Chelation Therapy for Mucormycosis. Antimicrobial Agents and Chemotherapy. 53(7). 3122–3125. 72 indexed citations
18.
Hedderwick, S., Hector Bonilla, Neil L. Barg, Robert D. Arbeit, & Carol A. Kauffman. (1997). Mycobacterium avium complex endocarditis: Spurious diagnosis resulting from laboratory cross contamination. Diagnostic Microbiology and Infectious Disease. 27(4). 147–150. 3 indexed citations
19.
Bonilla, Hector, et al.. (1997). Mycoplasma felis Septic Arthritis in a Patient with Hypogammaglobulinemia. Clinical Infectious Diseases. 24(2). 222–225. 39 indexed citations
20.
Bonilla, Hector, Lidija T. Zarins, Suzanne Bradley, & Carol A. Kauffman. (1996). Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacin. Diagnostic Microbiology and Infectious Disease. 26(1). 17–21. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026